大禹生物
(871970)
| 流通市值：3.61亿 | | | 总市值：5.79亿 |
| 流通股本：6944.59万 | | | 总股本：1.11亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 89,245,304.8 | 57,253,634.38 | 25,100,709.69 | 160,576,693.07 |
| 营业收入 | 89,245,304.8 | 57,253,634.38 | 25,100,709.69 | 160,576,693.07 |
| 二、营业总成本 | 108,779,005.81 | 70,116,632.08 | 30,762,109.13 | 168,953,762.4 |
| 营业成本 | 67,439,901.2 | 43,634,214.94 | 19,121,934.9 | 116,777,847.23 |
| 税金及附加 | 1,209,822.09 | 1,060,388.35 | 69,122.61 | 1,477,272.32 |
| 销售费用 | 11,352,942.59 | 6,852,585.24 | 3,227,327.55 | 18,730,984.45 |
| 管理费用 | 20,376,309.51 | 12,910,864.22 | 5,563,313.76 | 19,725,003.49 |
| 研发费用 | 6,643,893.8 | 4,480,393.69 | 2,226,327.07 | 10,260,570.09 |
| 财务费用 | 1,756,136.62 | 1,178,185.64 | 554,083.24 | 1,982,084.82 |
| 其中:利息费用 | 1,773,421.15 | 1,190,522.25 | 558,963.89 | 2,154,941.66 |
| 其中:利息收入 | 34,300.87 | 23,733.98 | 11,890.65 | 198,564.51 |
| 资产处置收益 | - | - | - | 299,352.14 |
| 资产减值损失(新) | -128,898.4 | -72,940.68 | - | -478,103.82 |
| 信用减值损失(新) | -730,386.79 | -341,040.08 | -17,948.13 | -552,502.88 |
| 其他收益 | 4,305,456.31 | 2,779,277.7 | 1,228,473.07 | 7,240,028.8 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -16,087,529.89 | -10,497,700.76 | -4,450,874.5 | -1,868,295.09 |
| 加:营业外收入 | 47,410.53 | 47,410.45 | 0.45 | 22,458 |
| 减:营业外支出 | 77,183.57 | - | - | 503,540.76 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,349,377.85 |
| 减:所得税费用 | - | - | - | -259,607.4 |
| 六、净利润 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,089,770.45 |
| 持续经营净利润 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,089,770.45 |
| 归属于母公司股东的净利润 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,089,770.45 |
| (一)基本每股收益 | -0.14 | -0.09 | -0.04 | -0.02 |
| (二)稀释每股收益 | -0.14 | -0.09 | -0.04 | -0.02 |
| 九、综合收益总额 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,089,770.45 |
| 归属于母公司股东的综合收益总额 | -16,117,302.93 | -10,450,290.31 | -4,450,874.05 | -2,089,770.45 |
| 公告日期 | 2024-10-28 | 2024-08-28 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |